Hundreds of Lymphoma Patients and Loved Ones Set to Attend Nation’s Most Comprehensive Lymphoma Education Program
New York, NY (October 5, 2017) –The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – will host its North American Educational Forum on Lymphoma from October 20-22, 2017 at the New York Marriott at the Brooklyn Bridge. This two and a half day program represents the most comprehensive lymphoma-specific educational conference in North America, providing critical information on treatment options, patient support issues, clinical trials and the latest advances in lymphoma research to people with lymphoma and their loved ones.
Each year, the Lymphoma Research Foundation hosts hundreds at the annual Educational Forum, providing them a unique opportunity to learn from some of the world’s leading lymphoma experts, as well as network with others who have a shared experience. Andrew M. Evens, DO, MSc, Tufts Cancer Center, Tufts Medical Center, Kara Kelly, MD, Roswell Park Cancer Institute, and Eduardo M. Sotomayor, MD, GW Cancer Center, George Washington University will co-chair this year’s program.
Each year, the North American Educational Forum on Lymphoma includes disease-specific breakout sessions, expert panel presentations, treatment updates, and unique networking opportunities to those affected by lymphoma. Dr. Bruce Cheson, MD, FACP, FAAAS, Georgetown University Hospital Lombardi Comprehensive Cancer Center, Past Chair of LRF’s Scientific Advisory Board and Dr. Stephen J. Schuster, MD, Hospital of the University of Pennsylvania will host a dedicated educational lunch program on Immune Oncology. During this session, patients can learn more about immunotherapy and this new approval of CAR-T cell therapy and ask questions of leading experts in the field.
“It is critical for patients and their loved ones to have access to the most up to date information about their disease, and the leading lymphoma experts to learn about their specific lymphoma subtype,” said Meghan Gutierrez, LRF Chief Executive Officer. “Not only does the Lymphoma Research Foundation’s Educational Forum provide members of the lymphoma community with an opportunity to further engage with and understand their treatment options, but it also underscores the patient-centric approach that is so vital to our mission.”
The 2017 North American Educational Forum on Lymphoma is supported by unrestricted educational grants from National Presenting Supporter Genentech | Biogen, National Platinum Supporter Celgene, National Gold Supporters AbbVie, Gilead Sciences, Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc., National Silver Supporters AstraZeneca, Bayer, Bristol-Myers Squibb, Novartis and Seattle Genetics, and National Bronze Supporters Epizyme, Juno Therapeutics, Kite, a Gilead Company, Mallinckrodt Pharmaceuticals, Merck, Spectrum Pharmaceuticals and Teva Pharmaceuticals.
For more information or to register for the Lymphoma Research Foundation’s North American Educational Forum on Lymphoma, visit lymphoma.org/EdForum.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded nearly $60 million in lymphoma-specific research.
For additional information on LRF’s research, education and services, visit lymphoma.org.